Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Rockwell Automation introduces three Allen-Bradley compute products October 31, 2017 RBI tells Catholic Syrian Bank to settle valuation issues with Prem Watsa’s Fairfax May 31, 2017 CAS Dataloggers announces Novus DigiRail Connect distributed I/O module October 28, 2019